The US Food and Drug Administration has issued 47 medical device safety communications throughout 2024, reflecting enhanced regulatory vigilance over technologies used in healthcare systems worldwide. These critical alerts address malfunctions in ventilators, surgical robots, cardiac monitoring devices, and other essential clinical equipment that directly impact patient outcomes.
The FDA’s Center for Devices and Radiological Health maintains continuous post-market surveillance through mandatory adverse event reporting and routine facility inspections. With an average of 3.9 alerts per month, this systematic approach ensures that healthcare providers receive timely notification of potential device risks before patient harm occurs. Since FDA-approved devices circulate through European and Asian healthcare networks, these safety communications carry significant international implications, enabling clinicians globally to implement protective measures and maintain treatment safety standards.
Read the full article on GMJ Newsroom.
Was this article helpful?
